Takashi Yoshiyama

Summary

Affiliation: Research Institute of Tuberculosis
Country: Japan

Publications

  1. ncbi request reprint Prevalence of drug-resistant tuberculosis in an HIV endemic area in northern Thailand
    T Yoshiyama
    Research Institute of Tuberculosis, Kiyose Tokyo, Japan
    Int J Tuberc Lung Dis 5:32-9. 2001
  2. ncbi request reprint [Comparison of effectiveness of BCG vaccination and preventive therapy in Japanese settings, with special emphasis on the sensitivity and specificity of tuberculin testing]
    Takashi Yoshiyama
    Epidemiology Division, Research Institute of Tuberculosis, Japan Anti Tuberculosis Association, 3 1 24, Matsuyama, Kiyose shi, Tokyo 204 8533, Japan
    Kekkaku 77:11-22. 2002
  3. ncbi request reprint [Tuberculosis contact examination and QFT-G testing for the prevention of hospital acquired infection]
    Takashi Yoshiyama
    Fukujuji Hospital, Japan Anti Tuberculosis Association JATA, Tokyo, Japan
    Kekkaku 85:601-7. 2010
  4. ncbi request reprint Risk of relapse and failure after retreatment with the Category II regimen in Nepal
    T Yoshiyama
    Research Institute of Tuberculosis, Tokyo, Japan
    Int J Tuberc Lung Dis 14:1418-23. 2010
  5. ncbi request reprint [A comparative study on severity of tuberculosis cases between those found by periodical chest X-ray examination and those found by symptomatic visit to OPD in Japan]
    Takashi Yoshiyama
    Department of Research, Research Institute of Tuberculosis, 3 1 24, Matsuyama, Kiyose shi, Tokyo 204 8533, Japan
    Kekkaku 78:427-34. 2003
  6. ncbi request reprint Development of acquired drug resistance in recurrent tuberculosis patients with various previous treatment outcomes
    T Yoshiyama
    Epidemiology Division, Research Institute of Tuberculosis, Kiyose, Tokyo, Japan
    Int J Tuberc Lung Dis 8:31-8. 2004
  7. ncbi request reprint [Relapse rate of pulmonary tuberculosis within two years following completion of twice weekly intermittent chemotherapy]
    Masako Wada
    Research Institute of Tuberculosis, Japan Anti Tuberculosis Association JATA, Tokyo
    Kekkaku 83:353-8. 2008
  8. ncbi request reprint [Factors related to the occurrence of multi- (extensively-) drug resistant tuberculosis (M/XDR-TB) in our hospital]
    Masao Okumura
    Department of Respiratory Medicine, Fukujuji Hospital, Japan Anti Tuberculosis Association JATA, Tokyo, Japan
    Kekkaku 86:863-8. 2011
  9. ncbi request reprint Analysis of an interferon-gamma release assay for monitoring the efficacy of anti-tuberculosis chemotherapy
    Kiyoko Takayanagi
    Department of Respiratory Medicine, Double Barred Cross Hospital, Japan Anti Tuberculosis Association, Tokyo 204 8533, Japan
    Jpn J Infect Dis 64:133-8. 2011
  10. ncbi request reprint [Treatment results of rifampicin (RFP) resistant isoniazid (INH) susceptible tuberculosis, a hospital based study]
    Takashi Yoshiyama
    Fukujuji Hospital, Japan Anti Tuberculosis Association, Kiyose shi, Tokyo, Japan
    Kekkaku 82:95-101. 2007

Collaborators

Detail Information

Publications71

  1. ncbi request reprint Prevalence of drug-resistant tuberculosis in an HIV endemic area in northern Thailand
    T Yoshiyama
    Research Institute of Tuberculosis, Kiyose Tokyo, Japan
    Int J Tuberc Lung Dis 5:32-9. 2001
    ..Chiang Rai Province in Northern Thailand, where human immunodeficiency virus (HIV) infection has been prevalent since the 1990s...
  2. ncbi request reprint [Comparison of effectiveness of BCG vaccination and preventive therapy in Japanese settings, with special emphasis on the sensitivity and specificity of tuberculin testing]
    Takashi Yoshiyama
    Epidemiology Division, Research Institute of Tuberculosis, Japan Anti Tuberculosis Association, 3 1 24, Matsuyama, Kiyose shi, Tokyo 204 8533, Japan
    Kekkaku 77:11-22. 2002
    ..No discussion has been done on the disadvantage of BCG vaccination from the point of view of loss of sensitivity and specificity of tuberculin test on the diagnosis of LTBI...
  3. ncbi request reprint [Tuberculosis contact examination and QFT-G testing for the prevention of hospital acquired infection]
    Takashi Yoshiyama
    Fukujuji Hospital, Japan Anti Tuberculosis Association JATA, Tokyo, Japan
    Kekkaku 85:601-7. 2010
    ..Therefore, periodical QFT is recommended for the staff working at the environment with high risk of infection (around 2% per year)...
  4. ncbi request reprint Risk of relapse and failure after retreatment with the Category II regimen in Nepal
    T Yoshiyama
    Research Institute of Tuberculosis, Tokyo, Japan
    Int J Tuberc Lung Dis 14:1418-23. 2010
    ..Kathmandu Valley urban area, Nepal...
  5. ncbi request reprint [A comparative study on severity of tuberculosis cases between those found by periodical chest X-ray examination and those found by symptomatic visit to OPD in Japan]
    Takashi Yoshiyama
    Department of Research, Research Institute of Tuberculosis, 3 1 24, Matsuyama, Kiyose shi, Tokyo 204 8533, Japan
    Kekkaku 78:427-34. 2003
    ..Japanese national tuberculosis control program (NTP) has included indiscriminate chest X-ray examination for adult population...
  6. ncbi request reprint Development of acquired drug resistance in recurrent tuberculosis patients with various previous treatment outcomes
    T Yoshiyama
    Epidemiology Division, Research Institute of Tuberculosis, Kiyose, Tokyo, Japan
    Int J Tuberc Lung Dis 8:31-8. 2004
    ..Chiang Rai province, Northern Thailand...
  7. ncbi request reprint [Relapse rate of pulmonary tuberculosis within two years following completion of twice weekly intermittent chemotherapy]
    Masako Wada
    Research Institute of Tuberculosis, Japan Anti Tuberculosis Association JATA, Tokyo
    Kekkaku 83:353-8. 2008
    ..To evaluate the relapse rate after treatment of a twice weekly intermittent chemotherapy during continuation phase in the patients with pulmonary tuberculosis in two years period after completion of chemotherapy...
  8. ncbi request reprint [Factors related to the occurrence of multi- (extensively-) drug resistant tuberculosis (M/XDR-TB) in our hospital]
    Masao Okumura
    Department of Respiratory Medicine, Fukujuji Hospital, Japan Anti Tuberculosis Association JATA, Tokyo, Japan
    Kekkaku 86:863-8. 2011
    ..To analyze the clinical characteristics of multi- (extensively-) drug-resistant tuberculosis (M/XDR-TB) in our hospital...
  9. ncbi request reprint Analysis of an interferon-gamma release assay for monitoring the efficacy of anti-tuberculosis chemotherapy
    Kiyoko Takayanagi
    Department of Respiratory Medicine, Double Barred Cross Hospital, Japan Anti Tuberculosis Association, Tokyo 204 8533, Japan
    Jpn J Infect Dis 64:133-8. 2011
    ..Although it was shown that anti-tuberculosis treatment generally reduced the specific release of IFN-╬│, the effect is so variable that it could be used as a monitor of progress of chemotherapy with great care and reservation...
  10. ncbi request reprint [Treatment results of rifampicin (RFP) resistant isoniazid (INH) susceptible tuberculosis, a hospital based study]
    Takashi Yoshiyama
    Fukujuji Hospital, Japan Anti Tuberculosis Association, Kiyose shi, Tokyo, Japan
    Kekkaku 82:95-101. 2007
    ..To evaluate treatment results of Rifampicin (R) resistant Isoniazid (H) susceptible tuberculosis cases...
  11. ncbi request reprint Computerized surveillance system of tuberculosis in Japan: its evolution, achievement and challenges
    Masako Ohmori
    The Research Institute of Tuberculosis, Japan Anti Tuberculosis Association JATA, Tokyo, Japan
    Kekkaku 87:15-23. 2012
    ..An important role of the Research Institute of Tuberculosis is to support the planning and execution of TB control with provision of useful epidemiological information from the system...
  12. ncbi request reprint [Risk of acquisition of RFP resistance out of INH resistant RFP susceptible tuberculosis]
    Takashi Yoshiyama
    Research Institute of Tuberculosis, Japan Anti Tuberculosis Association JATA
    Kekkaku 80:9-14. 2005
    ..To investigate the prognosis of isoniazid (H) resistant rifampicin (R) susceptible tuberculosis cases with emphasis on the risk factors of developing MDR...
  13. ncbi request reprint [A case of multidrug-resistant pulmonary tuberculosis cured by the regimen including thiacetazone]
    Masako Wada
    Research Institute of Tuberculosis, JATA, 3 1 24, Matsuyama, Kiyose shi, Tokyo 204 8533 Japan
    Kekkaku 82:33-7. 2007
    ..We considered thiacetazone was effective in this case, because all of the drugs was companied with thiacetazone were resistant by the drug susceptibility tests and were previously used...
  14. ncbi request reprint Clinical factors on cavitary and nodular bronchiectatic types in pulmonary Mycobacterium avium complex disease
    Masao Okumura
    Respiratory Medicine Section, Fukujuji Hospital, Japan Anti Tuberculosis Association, Kiyose
    Intern Med 47:1465-72. 2008
    ..We analyzed the clinical feature of these two radiologically different types and identified their prognostic factors...
  15. ncbi request reprint [Should chemotherapy for pulmonary tuberculosis be started after the completion of pretreatment sputum examination?]
    Kunihiko Ito
    Department of Research, Research Institute of Tuberculosis, JATA, 3 1 24, Matsuyama, Kiyose shi, Tokyo 204 8533, Japan
    Kekkaku 80:735-41. 2005
    ..Investigation on the influence of early start of chemotherapy on the results of sputum smear and culture (Ogawa medium and BACTEC MGIT960)...
  16. ncbi request reprint [Adverse effect other than liver dysfunction in treatment of latent tuberculous infection by isoniazid]
    Kunihiko Ito
    Research Institute of Tuberculosis, JATA, 3 1 24, Matsuyama, Kiyose shi, Tokyo 2048533 Japan
    Kekkaku 82:1-9. 2007
    ..To study the frequency and degree of adverse effect, other than liver dysfunction, of isoniazid (INH) preventive therapy in Japanese people...
  17. ncbi request reprint [Case of multi-drug resistant pulmonary tuberculosis with bilateral cavitary lesions successfully treated by surgical treatment]
    Masao Okumura
    Department of Respiratory Medicine, Fukujuji Hospital, Tokyo, Japan
    Kekkaku 82:831-5. 2007
    ..This case was a difficult case to treat because of bilateral cavitary lesions. However he was successfully treated by the surgical treatment...
  18. ncbi request reprint [Process of acquiring drug resistance: retrospective review of records of MDR TB]
    Takashi Yoshiyama
    Research Institute of Tuberculosis, Japan Anti Tuberculosis Association JATA
    Kekkaku 79:717-24. 2004
    ..To investigate the reasons of acquiring drug resistance among MDR TB cases and to learn lessons for the prevention of acquiring of drug resistance...
  19. ncbi request reprint [Miss-management in treatment failure of pulmonary tuberculosis]
    Kunihiko Ito
    Department of Research, Research Institute of Tuberculosis, Japan Anti Tuberculosis Association JATA, Tokyo
    Kekkaku 79:561-7. 2004
    ..To investigate the risk factor of treatment failure of pulmonary tuberculosis excluding multi-drug resistant cases from the standpoint of both clinical management and tuberculosis control...
  20. ncbi request reprint [What is needed to prevent defaulting from tuberculosis treatment?]
    Kunihiko Ito
    Research Institute of Tuberculosis, JATA, 3 1 24, Matsuyama, Kiyose shi, Tokyo 204 8533 Japan
    Kekkaku 83:621-8. 2008
    ..To investigate the factors relating to defaulting from tuberculosis treatment in Japan, and clarify what is needed to prevent defaulting...
  21. ncbi request reprint [Twice-weekly intermittent chemotherapy during the maintenance phase of the short-course treatment for new patients with pulmonary tuberculosis]
    Masako Wada
    Research Institute of Tuberculosis, JATA, 3 1 24, Matsuyama, Kiyose shi, Tokyo 204 8533 Japan
    Kekkaku 81:363-9. 2006
    ..To introduce DOT more extensively in Japan, we conducted the present clinical trial to assess the effectiveness and safety of intermittent chemotherapy...
  22. ncbi request reprint [Clinical experience using rifabutin for treating infection with Mycobacterium tuberculosis in elderly Japanese patients]
    Kozo Morimoto
    Fukujuji Hospital, Japan Anti Tuberculosis Association, Tokyo, Japan
    Kekkaku 88:625-8. 2013
    ..To clarify whether rifabutin (RBT) can be used for treating tuberculosis in elderly Japanese patients in the clinical setting...
  23. doi request reprint A steady increase in nontuberculous mycobacteriosis mortality and estimated prevalence in Japan
    Kozo Morimoto
    1 Respiratory Disease Center, Fukujuji Hospital, Japan Anti Tuberculosis Association
    Ann Am Thorac Soc 11:1-8. 2014
    ..Pulmonary disease caused by nontuberculous mycobacteria is generally reported to have a good prognosis. However, the actual mortality rate over time has not been reported in a large-scale survey...
  24. ncbi request reprint [Liver damage in treatment of latent tuberculous infection by isoniazid]
    Kunihiko Ito
    Research Institute of Tuberculosis, Japan Anti Tuberculosis Association JATA
    Kekkaku 81:651-60. 2006
    ..To study the frequency and degree of liver damage as adverse effect of isoniazid (INH) preventive therapy in Japanese people...
  25. ncbi request reprint [The use of nationwide tuberculosis surveillance system data to determine geographical differences in drug resistance--consideration of the representativeness of the drug resistance rate in Japan]
    Masako Ohmori
    Research Institute of Tuberculosis, Japan Anti Tuberculosis Association JATA, Tuberculosis Surveillance Center, Tokyo, Japan
    Kekkaku 86:729-35. 2011
    ....
  26. ncbi request reprint [Multi-drug resistant lung tuberculosis due to double infection of MDR strain]
    Kunihiko Ito
    Department of Research, Mycobacterium Reference Center, Research Institute of Tuberculosis, Japan Anti Tuberculosis Association, Department of Research, Tokyo
    Kekkaku 79:387-90. 2004
    ..The case was considered to be caused by the double infection of MDR strain of Mycobacterium tuberculosis during the course of treatment for tuberculosis due to a sensitive strain of Mycobacterium tuberculosis...
  27. ncbi request reprint Nutritional indicators are correlated with the radiological severity score in patients with Mycobacterium avium complex pulmonary disease: a cross-sectional study
    Kozo Morimoto
    Respiratory Disease Center, Fukujuji Hospital, Japan Anti Tuberculosis Association, Japan
    Intern Med 53:397-401. 2014
    ..This cross-sectional study aimed to compare the nutritional status and radiological severity scores in MAC pulmonary disease patients...
  28. ncbi request reprint [Nontuberculous mycobacteriosis mortality in Japan]
    Kozo Morimoto
    Respiratory Center, Fukujuji Hospital, Japan Anti Tuberculosis Association
    Kekkaku 86:547-52. 2011
    ..In addition, changes in the proportions of death cases due to NTM disease among total autopsies were calculated using the Annual of the Pathological Autopsy in Japan (The Japanese Society of Pathology)...
  29. ncbi request reprint [Bacteriological and pathological analysis on the pathogenetic factors for cavitary and nodular bronchiectatic type of pulmonary Mycobacterium avium-intracellulare complex disease]
    Masao Okumura
    Department of Respiratory Medicine, Fukujuji Hospital, Japan Anti Tuberculosis Association
    Nihon Kokyuki Gakkai Zasshi 44:91-8. 2006
    ....
  30. ncbi request reprint [CT screening before treatment of latent tuberculous infection for the diagnosis of clinical TB among contacts]
    Takashi Yoshiyama
    Fukujuji Hospital, JATA, 3 1 24, Matsuyama, Kiyose shi, Tokyo 204 8522, Japan
    Kekkaku 83:411-6. 2008
    ..To evaluate the value of CT scan for the detection of tuberculous diseases among persons who are suspected to be infected at the contact examination...
  31. ncbi request reprint [New cohort analysis system in new tuberculosis surveillance system in Japan]
    Hitoshi Hoshino
    Research Institute of Tuberculosis, Japan Anti Tuberculosis Association, Tokyo
    Kekkaku 82:897-901. 2007
    ..To know factors to influence treatment outcome of new cohort analysis method in revised TB surveillance system and important points for quality improvement of the system using hospital based real data of TB patients...
  32. doi request reprint Comparison of the sensitivity and specificity of two whole blood interferon-gamma assays for M. tuberculosis infection
    Nobuyuki Harada
    The Research Institute of Tuberculosis, 3 1 24, Matsuyama, Kiyose City, Tokyo 204 8533, Japan
    J Infect 56:348-53. 2008
    ..To compare the sensitivity and the specificity of the QuantiFERON-TB Gold (QFT-G) and QuantiFERON-TB Gold In Tube (QFT-GIT) diagnostic tests for Mycobacterium tuberculosis infection...
  33. ncbi request reprint [Tuberculosis control in Shinjuku Ward, Tokyo--promoting the DOTS program and its outcome]
    Sumi Kaguraoka
    Nishishinjuku Public Health Centre, Tokyo, Japan
    Kekkaku 83:611-20. 2008
    ..Therefore, one of the important TB programs in Shinjuku has been to actively detect cases among high-risk groups such as foreigners and the homeless...
  34. ncbi request reprint Linezolid as a potentially effective drug for the treatment of multidrug-resistant tuberculosis in Japan
    Lina Yi
    Respiratory Disease Center, Fukujuji Hospital, Japan Anti Tuberculosis Association
    Jpn J Infect Dis . 2016
    ..Our study showed that LZD might be clinically effective in the treatment of M/XDR-TB cases in Japan...
  35. doi request reprint Clinical and microbiological features of definite Mycobacterium gordonae pulmonary disease: the establishment of diagnostic criteria for low-virulence mycobacteria
    Kozo Morimoto
    Respiratory Disease Center, Fukujuji Hospital, Japan Anti Tuberculosis Association, 3 1 24, Matsuyama Kiyose, Tokyo, Japan Department of Mycobacterial References and Research, The Research Institute of Tuberculosis, Japan Anti Tuberculosis Association, 3 1 24, Matsuyama Kiyose, Tokyo, Japan
    Trans R Soc Trop Med Hyg 109:589-93. 2015
    ..gordonae can cause definite pulmonary disease. The establishment of a standard diagnostic criteria of pulmonary disease that is caused by this low virulence mycobacterium is obviously necessary...
  36. ncbi request reprint [Clinical factors of pulmonary tuberculosis in non-tuberculosis wards and its incidence among contact patients and healthcare workers in our hospital using QuantiFERON GOLD testing]
    Masao Okumura
    Department of Respiratory Medicine, Fukujuji Hospital, Japan Anti Tuberculosis Association JATA, 3 1 24, Matsuyama, Kiyose shi, Tokyo 204 8522 Japan
    Kekkaku 88:605-9. 2013
    ..In our hospital, we analyzed the clinical factors of pulmonary tuberculosis (TB) diagnosed in non-TB wards and the incidence of TB infection among contact patients and healthcare workers (HCWs) using QuantiFERON-TB GOLD (QFT) testing...
  37. ncbi request reprint [Estimating the prevalence of tuberculosis infection among healthcare workers in our hospital by repeat QFT-G testing]
    Masao Okumura
    Department of Respiratory Medicine, Fukujuji Hospital, Japan Anti Tuberculosis Association, 3 1 24, Matsuyama, Kiyose shi, Tokyo 204 8522, Japan
    Kekkaku 88:405-9. 2013
    ..The QuantiFERON-TB (QFT) blood test is the major tool for the diagnosis of Mycobacterium tuberculosis (TB) infection among healthcare workers (HCWs). We used QFT tests to estimate the prevalence of TB infection among HCWs in our hospital...
  38. ncbi request reprint Mycobacterium heckeshornense lung infection that was diagnosed as Mycobacterium xenopi disease by DNA-DNA hybridization (DDH)
    Kozo Morimoto
    Fukujuji Hospital, Japan Anti Tuberculosis Association, Japan
    Intern Med 50:1251-3. 2011
    ..And it was diagnosed as M. xenopiby DDH method. Chest X-ray showed fibrocavitary lesion in right upper lobe was successfully treated with clarithromycin for four weeks...
  39. doi request reprint Comparison of performance in two diagnostic methods for tuberculosis infection
    Kazue Higuchi
    The Research Institute of Tuberculosis, Japan Anti Tuberculosis Association, Kiyose, Tokyo, Japan
    Med Microbiol Immunol 198:33-7. 2009
    ..The difference in the performance between T-SPOT and QFT-G and biological relevance of each system in diagnosing M. tuberculosis infection should be further explored...
  40. ncbi request reprint [Number of sputum cultures by MGIT system needed to diagnose pulmonary tuberculosis]
    Kunihiko Ito
    Department of Research, Research Institute of Tuberculosis, Japan Anti Tuberculosis Association JATA, 3 1 24, Matsuyama, Kiyose shi, Tokyo 204 8533, Japan
    Kekkaku 81:511-8. 2006
    ..To study the number of sputum cultures by MGIT system (Becton-Dickinson) needed to diagnose pulmonary tuberculosis...
  41. doi request reprint Sub-speciation of Mycobacterium tuberculosis complex from tuberculosis patients in Japan
    Masako Ueyama
    Department of Respiratory Medicine, Fukujuji Hospital, Japan Anti Tuberculosis Association, Japan Department of Pulmonary Medicine and Oncology, Graduate School of Medicine, Nippon Medical School, Tokyo, Japan Electronic address
    Tuberculosis (Edinb) 94:15-9. 2014
    ..tuberculosis using the -215 narG nucleotide polymorphism. Though PCR-linked methods have been used for a rapid differentiation of MTC and NTM, from our cases we suggest careful interpretation of RD based identification. ..
  42. ncbi request reprint Multidrug-resistant tuberculosis with a history of nontuberculous Mycobacteriosis: a brief report of two cases
    Kozo Morimoto
    Fukujuji Hospital, Japan Anti Tuberculosis Association, Japan
    Intern Med 51:3435-7. 2012
    ..It is highly possible that these two patients were already infected with tuberculosis (TB) at the time of PNTM diagnosis and acquired resistance to anti-TB drugs as a result of undergoing treatment for PNTM...
  43. ncbi request reprint [C-reactive protein in patients with bacteriological positive lung tuberculosis]
    Kunihiko Ito
    Department of Research, Research Institute of Tuberculosis, Fukujuji Hospital, Japan Anti Tuberculosis Association, Tokyo, Japan
    Kekkaku 79:309-11. 2004
    ..To investigate the usefulness of measuring C-reactive protein in the diagnosis of lung tuberculosis...
  44. ncbi request reprint [Estimation of the future epidemiological situation of tuberculosis in Japan]
    Masako Ohmori
    Research Institute of Tuberculosis, Japan Anti Tuberculosis Association JATA, Tokyo
    Kekkaku 83:365-77. 2008
    ..e. pulmonary TB rate, sputum smear positive rate and its trend, to the estimated future number of TB incidence...
  45. doi request reprint Long term outcome of multidrug-resistant TB patients in Fukujuji Hospital in Japan
    Takashi Yoshiyama
    Respiratory Diseases Center, Fukujuji Hospital, 3 1 24 Matsuyama Kiyose, Tokyo, Japan
    Trans R Soc Trop Med Hyg 108:589-90. 2014
    ..To present the long-term outcome of multidrug-resistant tuberculosis (MDR TB) patients...
  46. ncbi request reprint [The background of drug-resistant tuberculosis patients on the basis of the annual report database for 2007-2009 in Japan]
    Masako Ohmori
    Tuberculosis Surveillance Center, Research Institute of Tuberculosis, JATA, 3 1 24, Matsuyama, Kiyose shi, Tokyo 204 8533, Japan
    Kekkaku 87:357-65. 2012
    ..However, the younger generations have become more susceptible to drug-resistant TB bacilli because anti-TB drugs were being widely used when they were born, and drug-resistant bacilli were prevalent in the world...
  47. ncbi request reprint [Analysis of Koch's phenomenon by BCg vaccination with the multi-puncture method in Japan]
    Seiya Kato
    Research Institute of Tuberculosis, Japan Anti Tuberculosis Association, 3 1 24, Matsuyama, Kiyose shi, Tokyo 204 8533, Japan
    Kekkaku 85:777-82. 2010
    ..The purpose of the present study was to clarify the issues and challenges regarding Koch's phenomenon in Japan...
  48. ncbi request reprint [Factors related to early case detection of tuberculosis in health service facilities for the elderly]
    Masako Ohmori
    Research Institute of Tuberculosis, JATA, 3 1 24, Matsuyama, Kiyose shi, Tokyo 204 8533, Japan
    Kekkaku 78:435-42. 2003
    ..Effective and feasible tuberculosis control for the elderly should be provided under the TB control Law and be implemented with the cooperation from related medical institutions and public health centers...
  49. ncbi request reprint [Drug resistance in recurrent cases of tuberculosis]
    Kunihiko Ito
    Department of Research, Research Institute of Tuberculosis, Japan Anti Tuberculosis Association, Tokyo, Japan
    Kekkaku 79:461-7. 2004
    ..Investigate drug resistant rate in recurrent cases after cure, or after drop-out from treatment, and the analysis of the risk factors for acquired drug resistance in these cases...
  50. ncbi request reprint [Problems in model-beds for tuberculosis patients]
    Kunihiko Ito
    Research Institute of Tuberculosis, Japan Anti Tuberculosis Association, Tokoyo, Japan
    Kekkaku 84:9-14. 2009
    ..To investigate the possibility and obstacles to care tuberculosis patients in general hospitals...
  51. ncbi request reprint [Are tuberculosis advisory committees well-functioning?]
    Kunihiko Ito
    Department of Research, Research Institute of Tuberculosis, JATA, Tokyo, Japan
    Kekkaku 79:631-5. 2004
    ..To evaluate the function status of TB advisory committee to assess treatments of tuberculosis...
  52. ncbi request reprint A Laboratory-Based Analysis of Nontuberculous Mycobacterial Lung Disease in Japan from 2012 to 2013
    Kozo Morimoto
    Fukujuji Hospital, Japan Anti Tuberculosis Association, Respiratory Disease Center, Kiyose, Japan
    Ann Am Thorac Soc . 2016
    ..Since 2010, studies that utilize mycobacterial examination results have been widely used to survey nontuberculous mycobacterial (NTM) lung disease...
  53. ncbi request reprint [Clinical analysis of extensively-drug resistant tuberculosis (XDR-TB) in our hospital]
    Masao Okumura
    Department of Respiratory Medicine, Fukujuji Hospital, Japan Anti Tuberculosis Association JATA
    Kekkaku 85:737-42. 2010
    ..We analyzed the clinical characteristics of extensively-drug resistant tuberculosis (XDR-TB)...
  54. pmc Characteristics and treatment outcomes of tuberculosis cases by risk groups, Japan, 2007-2010
    Kazuhiro Uchimura
    The Research Institute of Tuberculosis, Japan Anti Tuberculosis Association, Tokyo, Japan
    Western Pac Surveill Response J 4:11-8. 2013
    ..We studied the characteristics and treatment outcomes of the following risk groups for tuberculosis (TB): those with HIV and diabetes mellitus (DM), contact cases, the homeless, foreigners, health care workers (HCW) and the elderly...
  55. ncbi request reprint [Can an individual with a positive baseline QuantiFERON test result develop active tuberculosis?]
    Lina Yi
    Fukujuji Hospital, Japan Anti Tuberculosis Association
    Kekkaku 87:697-9. 2012
    ..However, the risk of development of active TB in the future depends on the period after the infection. The aim of this study was to evaluate the risk of development of active TB in individuals who have been infected...
  56. ncbi request reprint [Estimation of the number of necessary beds for tuberculosis patients, in Japan]
    Takashi Yoshiyama
    Department of Research, Research Institute of Tuberculosis, Japan Anti Tuberculosis Association JATA
    Kekkaku 79:553-60. 2004
    ..To estimate the number of necessary beds for tuberculosis patients in Japan from the view point of isolation of the source of infection...
  57. ncbi request reprint Current epidemiological trend of tuberculosis in Japan
    M Ohmori
    The Research Institute of Tuberculosis, Tokyo, Japan
    Int J Tuberc Lung Dis 6:415-23. 2002
    ..To observe the recent epidemiological trend of tuberculosis and to determine the factors related to the deteriorating trend in incidence and mortality rates in Japan...
  58. pmc Performance of an interferon-gamma release assay for diagnosing latent tuberculosis infection in children
    K Okada
    Japan International Cooperation Agency National Tuberculosis Control Project, Phnom Penh, Cambodia
    Epidemiol Infect 136:1179-87. 2008
    ....
  59. ncbi request reprint Trends of delays in tuberculosis case finding in Japan and associated factors
    M Ohmori
    Research Institute of Tuberculosis, Japan Anti Tuberculosis Association, Kiyose, Tokyo, Japan
    Int J Tuberc Lung Dis 9:999-1005. 2005
    ..Nationwide tuberculosis (TB) registry in Japan, 1987-2002...
  60. doi request reprint Use of the QuantiFERON®-TB Gold in Tube test for screening TB contacts and predictive value for active TB
    Takashi Yoshiyama
    From the 1 Respiratory Diseases Center, Fukujuji Hospital, Kiyose City, Japan
    Infect Dis (Lond) 47:542-9. 2015
    ..This study estimated the incidence of progression to active tuberculosis (TB) among contacts categorized by QuantiFERON(®)-TB Gold in Tube (QFT-GIT) test results and investigated other risk factors related to progression to TB...
  61. ncbi request reprint [Clinical studies on the pathogenetic factors of cavitary and nodular bronchiectatic types in pulmonary Mycobacterium avium complex disease]
    Masao Okumura
    Respiratory Medicine Section, Fukujuji Hospital, Japan Anti Tuberculosis Association
    Nihon Kokyuki Gakkai Zasshi 44:3-11. 2006
    ..The average age at death was 74.4 years old in men and 73.8 years old in women, and the two radiological patterns did not change throughout the entire disease course...
  62. ncbi request reprint [Treatment results of multi drug resistant tuberculosis, a hospital based study]
    Takashi Yoshiyama
    Fukujuji Hospital, JATA, 3 1 24, Matsuyama, Kiyose shi, Tokyo 204 8522 Japan
    Kekkaku 80:687-93. 2005
    ..Fukujuji Hospital, Japan...
  63. ncbi request reprint [Timing of quantiferon TB-G test for the contact examination of tuberculosis]
    Takashi Yoshiyama
    Fukujuji Hospital, Japan Anti Tuberculosis Association, 3 1 24, Matsuyama, Kiyose shi, Tokyo 204 8522, Japan
    Kekkaku 82:655-8. 2007
    ..To investigate the timing when Quanti FERON TB-Gold test (QFT-G) for the contact examination of tuberculosis should be done...
  64. ncbi request reprint [Preventive therapy in middle-aged and elderly persons selected from the population-based screening by mass miniature radiography--methodological aspect and adverse reactions]
    Masako Ohmori
    Research Institute of Tuberculosis, Okayama Institute of Health and Prevention, Japan
    Kekkaku 77:647-58. 2002
    ..However none of them was diagnosed clinically and bacteriologically as active tuberculosis...
  65. ncbi request reprint [Current status of multidrug-resistant tuberculosis in Japan: a literature review and meta-analysis]
    Toru Mori
    Research Institute of Tuberculosis, Japan Anti Tuberculosis Association JATA, Tokyo 204 8533, Japan
    Kekkaku 87:565-75. 2012
    ..This will be a major challenge to the promotion of clinical studies and the control of MDR-TB in Japan...
  66. doi request reprint Estimation of incidence of tuberculosis infection in health-care workers using repeated interferon-gamma assays
    T Yoshiyama
    Fukujuji Hospital, Matsuyama, Kiyose, Tokyo, Japan
    Epidemiol Infect 137:1691-8. 2009
    ..Criteria for defining QFT-G conversion and reversion need further investigation considering the high proportion of reversion, as the incidence of infection would have changed if we had applied other definitions...
  67. ncbi request reprint Exercise training for the improvement of exercise performance of patients with pulmonary tuberculosis sequelae
    Naoyuki Yoshida
    Department of Community and Family Medicine, Fukujuji Hospital, Japan Anti Tuberculosis Association, Tokyo
    Intern Med 45:399-403. 2006
    ..To examine whether exercise training using nontreadmill walking is effective for the improvement of exercise performance of patients with pulmonary tuberculosis sequelae (PTS) characterized by restrictive ventilatory defect...
  68. ncbi request reprint Use of the QuantiFERON-TB Gold test for screening tuberculosis contacts and predicting active disease
    T Yoshiyama
    First Clinical Department, Fukujuji Hospital, Tokyo, Japan
    Int J Tuberc Lung Dis 14:819-27. 2010
    ..To evaluate the performance of the QuantiFERON(R)-TB Gold (QFT-G) test for screening tuberculosis (TB) contacts and estimating their risk of progressing to active TB disease...
  69. ncbi request reprint [Results of repeated QFT-2G checkings at two-year interval and their comparison with TST results introduced into infection control program for staffs working at a hospital with isolation wards for tuberculosis]
    Yutsuki Nakajima
    National Hospital Organization Tokyo National Hospital, Japan
    Kekkaku 83:445-50. 2008
    ..Recently, a new technique, QFT-2G, is evaluated highly to detect TB infection, especially in BCG vaccinated individuals. We examined hospital staffs twice at two-year interval using QFT-2G and TST, and compared these data...
  70. ncbi request reprint A patient with a Mycobacterium avium complex infection complicated by systemic lupus erythematosus
    Kunio Takada
    First Department of Internal Medicine, National Defense Medical College, Tokorozawa, Saitama, Japan
    J Infect Chemother 10:49-52. 2004
    ..Owing to these therapeutic regimens, SLE was successfully treated without an exacerbation of the MAC infection. The risk factors for MAC infection and SLE are also discussed...
  71. ncbi request reprint Simple approximate backcalculation method applied to estimate HIV prevalence in Japan
    Hiroshi Nishiura
    Department of Infectious Disease Epidemiology, Faculty of Medicine, Imperial College London, London, England
    Jpn J Infect Dis 57:133-5. 2004